Effect of ATPase/ATP Synthetase
inhibitors on As(III) biosorption by Aspergillus niger X300
S. Ganguly*
Department of Biological Sciences, Sankrail Abhoy Charan High School (H.S), Sankrail,
Howrah, West Bengal, India
ABSTRACT:
An experimental study was conducted to
examine the involvement of metabolic energy in the biosorption
of As(III) by Aspergillus niger X300.
Five major inhibitors of ATPase was added to the
medium to inhibit ATPase. But no one exhibed adverse impact on the biosorption,
suggesting there by, biosorption of As (III) by Aspergillus niger X300
is not dependent on the cost of metabolic energy.
KEYWORDS:
Experimental, biosorption, Aspergillus niger X300,
inhibitors, ATPase
INTRODUCTION:
ATPase are a group of enzymes that
catalyze the hydrolysis of ATP into ADP into Pi[1].The decomposition releases
energy which drives biochemical reactions [2].Thus ,any process requires
metabolic energy cannot be operated when ATPase
activity is blocked by inhibitors.The present study
was intended to examine whether or not the biosorption
of As(III) by Aspergillus niger X300
requires metabolic energy.For this purpose , four
major ATPase inhibitors( namely:2,3 butanidione 2-monoxime, 4 hydroxynonenal,bafilomycin
A-1 and amiloride hydrochloride were examined.
MATERIALS AND METHODS:
Microorganism:
An experimentally developed As(III)
resistant strain Aspergillus niger X300
used throughout the study [3].
Physical condition
for fungal growth:
The following growth conditions were used
for optimum growth of the fungus: pH ,4.5; temperature, 300C; spore
density, 7x108 spores or cells/ml; shaker speed, 200 rpm, volume of
medium, 100ml, age of inoculum, 7 days and incubation period, 7 days[4].
Composition of synthetic
medium of the following composition of the synthetic medium was used in the
present study:
Glucose, 12%; (NH4)2SO4,
0,8%; K2HPO4,0.01% ; KH2PO4, 0.01%
; CaCl2.2H2O, 0.03%; NaCl,
0.02%; MgSO4.7H2O, 0.03%; MnSO4.4H2O, 0.02 µg/ml
and thiamine-HCl
,0.01µg/ml[5].
Estimation of
As(III):
The concentration of As(III) in the broth
was estimated by the method as reporte by Cernansky et al
.(2007) [6].
Estimation of
spore/ Dry cell weight:
Dry Spore/cell weight was estimated by the method
as proposed by Shah et al. (2000)[7].
Addition of ATPase inhibitors:
Full grown fungus were incubated in the
media containing As(III) and ATPase inhibitors (
0.01-0.08 mM /ml).
Statistical
analysis:
All data were expressed as mean± SEM ,where
n=6. Data were analyzed by one way ANOVA followed by Dunett’s
post hoc multiple comparison test considering p<0.05 as significant and
p<0.01 as highly significant using prism 4.0 (Graph pad inc., USA).
RESULTS:
|
TABLE 1 :
OPTIMIZATION OF CONTACT TIME BETWEEN Aspergillus niger X300 AND As(III) |
||
|
Time
(min) |
As(III)
concentration (mg/L) |
|
|
Initial |
Final |
|
|
00(Control) |
1500 |
1500.0±8.213 |
|
30 |
1500 |
*1325.6±5.991 |
|
45 |
1500 |
**1176.5±6.212 |
|
60 |
1500 |
**921.8±6.732 |
|
90 |
1500 |
**776.6±7.213 |
|
105 |
1500 |
**622.2±8.116 |
|
120 |
1500 |
**421.8±9.163 |
|
135 |
1500 |
**176.4±8.881 |
|
150 |
1500 |
**100.6±6.732 |
|
ʘ165 |
1500 |
**89.3±8.991 |
|
180 |
1500 |
**89.3±7.771 |
(Values were expressed
as Mean ± SEM , where n=6 ; *p<0.05, **p<0.01 when compared to control. ʘ stands for
maximum biosorption)
From this Table 1 it is clear that maximum biosorption was resulted by the full grown fungus at 165
minutes of contact.
|
TABLE 2: EFFECT OF
ATPase INHIBITORS ON As(III) BIOSORPTION BY Aspergillus niger X300 |
|||
|
Inhibitors |
Concentration(s) [Mm] |
As(III)
Biosorption (mg/L) |
|
|
Initial |
Final |
||
|
2, 3 butanidione 2-monoxime, 4 hydroxynonenal,
bafilomycin A-1 and amiloride
hydrochloride |
0.01 |
1500 |
**89.3±0.991 |
|
0.02 |
1500 |
**89.3±1.683 |
|
|
0.03 |
1500 |
**89.3±0.882 |
|
|
0.04 |
1500 |
**89.3±0.718 |
|
|
0.05 |
1500 |
**89.3±0.996 |
|
|
0.06 |
1500 |
**89.3±1.774 |
|
|
0.07 |
1500 |
**89.3±0.913 |
|
|
0.08 |
1500 |
**89.3±0.832 |
|
(Values were
expressed as Mean ± SEM , where n=6 ; *p<0.05, **p<0.01 when compared to
control.
From this table 2 , it can easily be stated
that , among these four ATPase inhibitors examined ,
none of them exerted any sort of significant effect on As(III) biosorption by this fungus. It can therefore be concluded
that , As(III) biosorption by this fungus is a
passive process,it doesnot
any sort of metabolic energy.
ACKNOWLEDGEMENT:
I express my sincere gratitude to the
Department of Chemical Engineering, University of Calcutta, Bose Institute,
Kolkata, Indian Institute of Chemical Biology (IICB), Kolkata, Department of
Food technology and Biochemical Engineering, Jadavpur
University, Kolkata for their kind cooperation.
REFERENCES:
1.
Glavinas H , Mehn D , Jain M , Oosterhuis B , Heredi SK and Krajcsi P
,Utilization of membrane vesicle preparations to study grug
ABC transporter interactions, Expert Openion on Drug Metabolism and Toxicology, 4, 2008:
721-732.
2.
Sarkadi B,
Price EM, Boucher RC, German UA and Scarborough GA, Expression of the human
multi drug resistant c-DNA in insect cells generates a high activity drug
stimulated membrane ATPase, Journal of Biological Chemistry, 267, 1992 : 4854-4858.
3.
Ganguly S,
Selection of suitable fungus , development of Arsenic resistant strain and
kinetic analysis for As(III) biosorption, Indian Journal of Applied Research ,
3,2013:9-10.
4.
Ganguly S ,
Optimization of Physical Conditions for As(III) Biosorption
by Aspergillus niger X300
, International Journal of Pharma medicine and Biological Sciences , 2 ,
2013:46-49.
5.
Ganguly S,
Selection of Suitable Synthetic Medium For As(III) Biosorption
By Aspergillus niger X300,
Asian Journal Research in Chemistry (in
press).
6.
Cernansky S , Urik M ,Sevc J and Khan M , Biosorption and Biovoltalization
of Arsenic by heat resistant fungus, Environmental
Science and Pollution Research ,14,2007 :31-35.
7.
Shah
AH, Hameed A and
Khan GM , Fermentative Production Of L-Lysine: Fungal Fermentation And Mutagenesis-II A Review, Pakistan Journal of
Pharmaceutical
Sciences,
15,2002:29-35.
Received on 12.04.2013
Modified on 16.05.2013
Accepted on 11.06.2013
© A&V Publication all right
reserved
Research J. Pharmacology and
Pharmacodynamics. 5(4): July–August 2013, 205-206